Patent Yard Sign in
Australian application, no grantAustralia

Use of 34-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia hypertriglyceridaemia hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment

AU 1996043292 · Applicant: Novo Nordisk As

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 10, 1996. Even if it was granted, its term would have ended by January 10, 2017.
  • A pharmaceutical extension adds at most five years, so even that would have ended by January 10, 2022.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 10, 1996
GrantedNo grant recorded
Term ended byJanuary 10, 2017
Application numberAU 1996043292
Classification (IPC)A61K31/35 +2 more

Timeline

Timeline From IP Australia dates

1997200020032006200920122015Application filedJan 10, 1996Term ended byJan 10, 2017

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.